Supplementary Table S3 from Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype

Ítems similars

• Supplementary Figure S1 from Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype
  per: Fleur M.G. Cornelissen (22761190)
  Publicat: (2025)
• Supplementary Figure S2 from Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype
  per: Fleur M.G. Cornelissen (22761190)
  Publicat: (2025)
• Supplementary Figure S3 from Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype
  per: Fleur M.G. Cornelissen (22761190)
  Publicat: (2025)
• Supplementary Figure S4 from Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype
  per: Fleur M.G. Cornelissen (22761190)
  Publicat: (2025)
• Supplementary Figure S5 from Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype
  per: Fleur M.G. Cornelissen (22761190)
  Publicat: (2025)